Pharma

Taking stock of the drug industry, from the lab to the medicine chest

California State flag
Pharmalot

California reports show changes in drug spending as two companies sue over disclosure

By Ed Silverman

Pharmalot

Gilead tussles with the Malaysian government over licensing for its hepatitis C treatment

By Ed Silverman

Pharmalot

Pharmalittle: A new year brings rising drug prices; Democratic presidential contenders target drug prices

By Ed Silverman

3 to Watch: Legislative Battles
Politics

3 state legislative battles to watch in 2019

By Lev Facher

3 to Watch: Lawmakers
Politics

3 freshman lawmakers to watch in 2019

By Nicholas Florko

World map medicine
Pharmalot

El Salvador is the latest Latin American country to worry pharma over compulsory licensing

By Ed Silverman

FDA Generic
Pharmalot

Canada ends a probe into three big drug makers accused of thwarting generic competition

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Drug prices may rise up to 9 percent next month; Novartis seeks to boost CAR-T manufacturing

By Ed Silverman

A dosage of Spinraza.
Pharmalot

Two high-priced drugs for spinal muscular atrophy are not cost effective, analysis concludes

By Ed Silverman

NHS
Pharmalot

Vertex and the U.K. government are at an impasse over a pricey cystic fibrosis drug — again

By Ed Silverman

Pill Dollars
Pharmalot

Get ready for drug prices to rise as much as 9 percent next month

By Ed Silverman

A photo of Hydrocodone Acetaminophen.
Pharmalot

New York law that forces opioid makers and distributors to pay surcharges is ruled unconstitutional

By Ed Silverman

Pharmalot

Pharmalittle: Drug makers to raise prices in January; Novartis names a new oncology chief, again

By Ed Silverman

Drug costs
Pharmalot

Trump administration report would preclude reclaiming patents as a way to lower drug prices

By Ed Silverman

Senators Opioid Report
Pharmalot

Wyden probes ties between opioid makers, advocacy groups, and a government panel

By Ed Silverman

Pharmalot

Pharmalittle: Glaxo and Pfizer will combine OTC businesses; Allergan recalls breast implants in Europe

By Ed Silverman

Budtender
Pharma

Novartis unit teams up with medical marijuana producer, marking milestone for pharma

By Elizabeth Cooney

Cow Growth Hormone
Pharmalot

Sales of antibiotics used in food-producing livestock dropped last year

By Ed Silverman

Pharmalot

Pharmalittle: China is first to approve a big pharma drug; J&J plans $5 billion stock buyback to blunt criticism

By Ed Silverman

Human Milk Bank
Health

Scientists turn to breast milk, and Mother Nature, to develop new therapeutics

By Meghana Keshavan

Pharmalot

Feds want to dismiss lawsuits alleging nurse educator programs are kickback schemes

By Ed Silverman

Pharmalot

Novartis braces for a battle over the cost effectiveness of a gene therapy

By Ed Silverman

FDA Campus
Pharmalot

Did an Indian toothpaste maker refuse an FDA inspection … again?

By Ed Silverman

Pharmalot

Pharmalittle: Novartis eyes reinsurance for pricey gene therapies; J&J hits back over talc report

By Ed Silverman

Drug pricing
Pharmalot

Pharma sales growth is being crimped as price hikes diminish

By Ed Silverman

Hires
Pharmalot

Up and down the ladder: The latest comings and goings

By Ed Silverman

Pharmalot

Pharmalittle: Former compounder employees convicted; Purdue must fork over secret records

By Ed Silverman

Opioid Crisis Lawsuits
Pharmalot

Philly city council tables ordinance to restrict sales reps after lobbying campaign

By Ed Silverman

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy